Novel Drug Approvals of 2020 – 2021 home study from 8/24
At the completion of the activity, the participant will be able to:
-List the Top 10 novel approved medications in 2020 and 2021
-Describe the therapeutic benefits and side effect profiles for each medication
-List the new medications and their place in therapy
Eric Ocheretyaner, PharmD, BCPS, BCIDP
Assistant Professor of Pharmacy Practice
Infectious Diseases Clinical Pharmacist
LIU Pharmacy (Arnold & Marie Schwartz College of Pharmacy and Health Sciences)
Brooklyn, New York
Dr. Eric Ocheretyaner earned his Doctorate degree in pharmacy at The Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University in Brooklyn, NY. He completed his PGY2 in Infectious Diseases and PGY1 Pharmacy Practice Residency at SUNY Downstate Medical Center, Brooklyn, NY. Dr. Ocheretyaner is currently an Assistant Professor of Pharmacy Practice and practices as an Infectious Diseases clinical pharmacist at Staten Island University Hospital Northwell Health. His research interests include HIV and multi-drug resistant bacterial infections.
ACPE UAN # 0042-0000-21-035-H04-P
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.